From: Preventive treatment can reverse cognitive impairment in chronic migraine
CM NMA (n = 14) \(\overline{\mathbf x}\;(\mathbf S\mathbf D)\) | Control group (n = 50) \(\overline{\mathbf x}\;(\mathbf S\mathbf D)\) | P Value | |
---|---|---|---|
Cognitive measures | |||
ROCF-c | 3261 (3.1) | 33.1 (2.96) | 0.504 |
ROCF-m | 18.46 (4.01) | 23.49 (5.45) | 0.001 |
TMT-A | 45.89 (20.89) | 42.61 (39.62) | 0.104 |
TMT-B | 92.97 (44.85) | 82.37 (58.95) | 0.111 |
Emotional state | |||
HADS—A | 5.64 (2.53) | 4.77 (2.42) | 0.165 |
HADS—D | 3.5 (1.7) | 2.02 (1.77) | 0.004 |
BDI-II | 5.64 (1.6) | 3.71 (3.3) | 0.040 |
Quality of life | |||
SF-36 PF | 80 (14.14) | 90.85 (19.39) | 0.000 |
SF-36 RP | 35.71 (38.87) | 86.22 (31.5) | 0.000 |
SF-36 BP | 35.36 (18.93) | 92.62 (99.79) | 0.000 |
SF-36 GH | 55.36 (12.16) | 73.05 (17.32) | 0.001 |
SF-36 VT | 48.04 (17.02) | 67.34 (17.57) | 0.001 |
SF-36 SF | 74.11 (24.25) | 89.02 (16.34) | 0.023 |
SF- 36 RE | 59.55 (47.47) | 91.07 (22.4) | 0.006 |
SF-36 MH | 66 (19.3) | 78.46 (12.41) | 0.022 |
PSQI-GS | 7.08 (3.68) | 4.98 (3.31) | 0.026 |